Sagespring Wealth Partners LLC Has $3.24 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Sagespring Wealth Partners LLC lifted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 5.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,371 shares of the company’s stock after acquiring an additional 522 shares during the period. Sagespring Wealth Partners LLC’s holdings in HCA Healthcare were worth $3,238,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Atwood & Palmer Inc. bought a new position in HCA Healthcare in the first quarter worth $28,000. Whipplewood Advisors LLC bought a new position in HCA Healthcare in the fourth quarter worth $31,000. Tidemark LLC bought a new position in shares of HCA Healthcare during the fourth quarter valued at $36,000. Legacy Investment Solutions LLC lifted its holdings in shares of HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company’s stock valued at $62,000 after acquiring an additional 95 shares during the period. Finally, Physician Wealth Advisors Inc. bought a new position in shares of HCA Healthcare during the fourth quarter valued at $64,000. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the company’s stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer now owns 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 1.30% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of analyst reports. Stephens raised HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Guggenheim initiated coverage on HCA Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating for the company. Baird R W cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 15th. Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a report on Monday, April 28th. Finally, Royal Bank of Canada lowered their price objective on HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating for the company in a research report on Monday, April 28th. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $392.47.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $370.76 on Monday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $89.20 billion, a P/E ratio of 16.88, a PEG ratio of 1.10 and a beta of 1.49. The business has a 50-day moving average of $358.43 and a 200-day moving average of $333.23.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business had revenue of $18.32 billion for the quarter, compared to analysts’ expectations of $18.26 billion. During the same quarter in the previous year, the business posted $5.36 EPS. HCA Healthcare’s revenue for the quarter was up 5.7% on a year-over-year basis. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.78%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare’s payout ratio is 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.